International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
Meet us
Careers
Contact
Business Development
Licensing
Strategic Therapeutic Areas
Territory
Partners & Brands
Testimonials
About Ewopharma
Vision/Mission
Our Values
Our Strategy
Leadership
Corporate Responsibility
Territory
Media
Meet us
Careers
Contact
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
PRESS RELEASES
1
2
3
4
Next
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Read more
15.04.2025
Exclusive Distribution Agreement for Cardiovascular Solutions in Bulgaria
Read more
31.07.2024
European Commission Approves Sugemalimab
Read more
03.06.2024
Allergycare AG becomes part of Ewopharma Group
Read more
27.05.2024
Ewopharma and CStone enter into a Strategic Partnership for Sugemalimab in Central Eastern Europe and Switzerland
Read more
1
2
3
4
Next
